Amar Kishan

Trials

Studies that name Amar Kishan as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 00:35 UTC. Open this list on ClinicalTrials.gov

• Ph3
  NCT07293585 · Vascular Optimized Radiotherapy Tuned to Critical Structures for Erectile Function Using High-Precision X-Ray Treatment

  Jonsson Comprehensive Cancer Center · recruiting · Prostate Cancer · principal investigator
• Ph2
  NCT07150715 · Alpha-Emitting Radionuclide or Beta-Emitting Radionuclide With Metastasis-Directed Stereotactic Body Radiotherapy for the Treatment of Recurrent, Oligometastatic Prostate Adenocarcinoma

  Jonsson Comprehensive Cancer Center · recruiting · Oligometastatic Prostate Adenocarcinoma, Recurrent Prostate Adenocarcinoma · principal investigator
• N/A
  NCT06995053 · Computed Tomography-Guided Stereotactic Body Radiation Therapy With Intrafraction Motion Monitoring for the Treatment of Localized Prostate Cancer, ILLUSION Trial

  Jonsson Comprehensive Cancer Center · active not recruiting · Localized Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8 · principal investigator
• Ph2
  NCT06067269 · Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Prostate Cancer, HEATWAVE Trial

  Jonsson Comprehensive Cancer Center · recruiting · Prostate Adenocarcinoma, Stage II Prostate Cancer AJCC v8, Stage IIIA Prostate Cancer AJCC v8 · principal investigator
• Ph2
  NCT05496959 · 177-Lutetium-PSMA Before Stereotactic Body Radiotherapy for the Treatment of Oligorecurrent Prostate Cancer, The LUNAR Study

  Jonsson Comprehensive Cancer Center · active not recruiting · Oligometastatic Prostate Carcinoma, Prostate Adenocarcinoma, Recurrent Prostate Adenocarcinoma · principal investigator
• Ph2
  NCT04915508 · Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical Prostatectomy

  Jonsson Comprehensive Cancer Center · active not recruiting · Prostate Adenocarcinoma, Stage IIIB Prostate Cancer American Joint Committee on Cancer (AJCC) v8, Stage IIIC Prostate Cancer AJCC v8 · principal investigator
• N/A
  NCT04624256 · Germline DNA-Based Radiosensitivity Biomarker Influence on Toxicity Following Prostate Radiotherapy, GARUDA Trial

  Jonsson Comprehensive Cancer Center · active not recruiting · Prostate Adenocarcinoma, Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8, Stage II Prostate Cancer AJCC v8 · principal investigator
• N/A
  NCT04384770 · CT-guided Stereotactic Body Radiation Therapy and MRI-guided Stereotactic Body Radiation Therapy for Prostate Cancer, MIRAGE Study

  Jonsson Comprehensive Cancer Center · active not recruiting · Prostate Adenocarcinoma · principal investigator
• Ph2
  NCT03902951 · Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate Cancer

  Jonsson Comprehensive Cancer Center · active not recruiting · Metastatic Prostate Adenocarcinoma, Prostate Adenocarcinoma With Focal Neuroendocrine Differentiation, Recurrent Prostate Carcinoma · principal investigator
• Ph2
  NCT03541850 · Stereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone Surgery

  Jonsson Comprehensive Cancer Center · active not recruiting · PSA Level Greater Than 0.03, PSA Progression, Stage I Prostate Adenocarcinoma AJCC (American Joint Committee on Cancer ) v7 · principal investigator
• N/A
  NCT02296229 · Stereotactic Body Radiation Therapy in Treating Patients With Localized High-Risk Prostate Cancer

  Jonsson Comprehensive Cancer Center · active not recruiting · Adenocarcinoma of the Prostate, Stage III Prostate Cancer · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 00:35 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.